BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7523465)

  • 1. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
    Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic alternatives in cutaneous T-cell lymphoma.
    Holloway KB; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
    Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
    J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
    [No Abstract]   [Full Text] [Related]  

  • 4. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
    Springer EA; Kuzel TM; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of cutaneous lymphoma ].
    Beylot-Barry M; Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferons for cutaneous T-cell lymphoma monotherapy or combination with PUVA.
    Roenigk HH; Kuzel T; Rosen S
    Australas J Dermatol; 1993; 34(1):13-5. PubMed ID: 8240181
    [No Abstract]   [Full Text] [Related]  

  • 8. Photopheresis for cutaneous T cell lymphoma.
    Heald PW
    Ann N Y Acad Sci; 1991 Dec; 636():171-7. PubMed ID: 1793207
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis.
    Haley HR; Davis DA; Sams WM
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):880-3. PubMed ID: 10534677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cutaneous T-cell lymphoma.
    Duhovic C; Child F; Wain EM
    Clin Med (Lond); 2012 Apr; 12(2):160-4. PubMed ID: 22586794
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cutaneous T-cell lymphomas: Established and emergent therapies.
    Wain T; Venning VL; Consuegra G; Fernandez-Peñas P; Wells J
    Australas J Dermatol; 2019 Aug; 60(3):200-208. PubMed ID: 30809800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
    Dippel E; Schrag H; Goerdt S; Orfanos CE
    Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous intravascular NK/T-cell lymphoma.
    Wang J; Yang X; Song Z; You Y
    Australas J Dermatol; 2020 Feb; 61(1):61-63. PubMed ID: 31372987
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal combination with PUVA: rationale and clinical trial update.
    Stadler R
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):29-32. PubMed ID: 17474357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment for cutaneous lymphomas.
    Mielke V; Staib G; Sterry W
    Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphoma: Biologic targets for therapy.
    Choi J; Foss F
    Curr Hematol Malig Rep; 2007 Oct; 2(4):272-7. PubMed ID: 20425380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.